The ADAP Advocacy Association (aaa+) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+ works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to assure that access to services recognize and afford persons living with HIV/AIDS to enjoy a healthy life.

aaa+ is the only national grassroots organization focused exclusively on ADAPs and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.

CLICK HERE TO VIEW PDF

ADAPs with Waiting Lists
(8,310 individuals in 13 states*, as of June 10, 2011)    (up from 6,235 in February 2011)

Alabama: 15 individuals
Arkansas: 59 individuals
Florida: 3,938 individuals
Georgia: 1,520 individuals
Idaho: 14
Louisiana: 696 individuals**
Montana: 26 individuals
North Carolina: 242 individuals
Ohio: 413 individuals
South Carolina: 693 individuals
Utah: 6
Virginia: 684 individuals
Wyoming: 4 individuals
 


ADAPs with Other Cost-Containment Strategies
(instituted since April 1, 2009, as of February 2, 2011)

Arizona: Reduced formulary
Arkansas: Reduced formulary, lowered financial eligibility to 200% FPL, (disenrolled 99 clients in September 2009)
Colorado: Reduced formulary
Florida: Reduced formulary, lower financial eligibility to 300% FPL, transition clients to Welvista from 2/14-3/31/11
Georgia: Reduced formulary, implemented medical criteria, continued participation in the Alternative Method Demonstration Project (AMDP)
Idaho: Capped enrollment
Illinois: Reduced formulary, instituted monthly expenditure cap
Kentucky: Reduced formulary
Louisiana: Discontinued reimbursement of laboratory assays
New Jersey: Reduced formulary
North Carolina: Reduced formulary
North Dakota: Capped enrollment, instituted annual expenditure cap, lowered financial eligibility to 300% FPL
Ohio: Reduced formulary, lowered financial eligibility to 300% FPL (disenrolled 257 clients in July 2010)
Puerto Rico: Reduced formulary
South Carolina: Lowered financial eligibility to 300% FPL
Utah: Reduced formulary, lowered financial eligibility to 250% FPL (disenrolled 89 clients in FY2010)
Virginia: Reduced formulary, only distribute 30-day prescription refills
Washington: Instituted client cost sharing, reduced formulary (for uninsured clients only), only pay insurance premium for clients currently on antiretrovirals
Wyoming: Reduced formulary, instituted client cost sharing
 

ADAPs Considering New/Additional Cost-Containment Measures
(before March 31, 2011***)

Alabama: Cap enrollment, establish waiting list (as of April 1, 2011), reduce formulary
Colorado: Institute client cost sharing
Idaho: Establish waiting list
Kentucky: Reduce formulary
Oregon: Reduce formulary
Puerto Rico: Reduce formulary
South Carolina: Disenroll 200 clients
Virginia: Transition 760 clients onto waiting list
Washington: Reduce formulary
Wyoming: Reduce formulary
 
*As a result of ADAP emergency funding, Hawaii, Idaho, Iowa, Kentucky, South Dakota, and Utah eliminated their waiting lists.
**Louisiana has a capped enrollment on their program. This number is a representation of their current unmet need.
***March 31, 2011 is the end of ADAP FY2010. ADAP fiscal years begin April 1 and end March 31.